Distribution of antiphospholipid antibodies in a large population-based German cohort

Clinical Chemistry and Laboratory Medicine

Volumn 54, Issue 10, 2016, Pages 1663-1670

  Manukyan, Davit ^a   Rossmann, Heidi ^a   Schulz, Andreas ^a   Zeller, Tanja ^b,c   Pfeiffer, Norbert ^a   Binder, Harald ^a   Münzel, Thomas ^a,c   Beutel, Manfred E ^a   Müller Calleja, Nadine ^a   Wild, Philipp S ^a,c   Lackner, Karl J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b UNIVERSITY HEART CENTER HAMBURG   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Antiphospholipid antibodies; General population; Reference range

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; ANTI-IGG; ANTI-IGM; ANTIIDIOTYPIC ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGE; AGED; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; FEMALE; GERMAN (CITIZEN); HUMAN; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEX DIFFERENCE; ANTIPHOSPHOLIPID SYNDROME; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GERMANY; IMMUNOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REFERENCE VALUE;

ADULT; AGED; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REFERENCE VALUES;

EID: 84987762010     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2016-0014     Document Type: Article

References (27)

1. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of the antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011;7:330-9.
2. Willis R, Harris EN, Pierangeli SS. Pathogenesis of the antiphos-pholipid syndrome. Semin Thromb Hemost 2012;38:305-21.
3. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphos-pholipid syndrome. N Engl J Med 2013;368:1033-44.
4. de Groot PG, Urbanus RT, Derksen RH. Pathophysiology of throm-botic APS: where do we stand? Lupus 2012;21:704-7.
5. Poulton K, Rahman A, Giles I. Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. Semin Arthritis Rheum 2012;41:720-36.
6. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phos-pholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycopro-tein I (apolipoprotein H). Proc Natl Acad Sci USA 1990;87:4120-4.
7. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7.
8. de Groot PG, Urbanus RT. The significance of autoantibodies against β2-glycoprotein I. Blood 2012;120:266-74.
9. Pelkmans L, de Laat B. Antibodies against domain I of β2-glycoprotein I: the one and only? Lupus 2012;21:769-72.
10. Moore GW. Recent guidelines and recommendations for laboratory detection of lupus anticoagulants. Semin Thromb Hemost 2014;40:163-71.
11. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
12. Montaruli B, De Luna E, Mengozzi G, Molinari F, Napolitano E, Napoli P, et al. Anti-cardiolipin and anti-β2-glycoprotein I antibodies: normal reference ranges in northwestern Italy. Lupus 2012;21:799-801.
13. De Moerloose P, Reber G, Musial J, Arnout J. Analytical and clinical performance of a new, automated assay panel for the diagnosis of antiphospholipid syndrome. J Thromb Haemost 2010;8:1540-6.
14. Van Hoecke F, Persijn L, Decavele AS, Devreese K. Performance of two new, automated chemiluminescence assay panels for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome. Int J Lab Hematol 2012;34:630-40.
15. Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
16. Wellek S, Lackner KJ, Jennen-Steinmetz C, Reinhard I, Hoffmann I, Blettner M. Determination of reference limits: statistical concepts and tools for sample size calculation. Clin Chem Lab Med 2014;52:1685-94.
17. Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol 1989;16:623-5.
18. Budd R, Harley E, Quarshie A, Henderson V, Harris EN, Pierangeli SS. A re-appraisal of the normal cut-off assignment for anticardi-olipin IgM tests. J Thromb Haemost 2006;4:2210-4.
19. Wild PS, Zeller T, Beutel M, Blettner M, Dugi KA, Lackner KJ, et al. The Gutenberg Health Study. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2012;55:824-9.
20. Michal M, Wiltink J, Lackner K, Wild PS, Zwiener I, Blettner M, et al. Association of hypertension with depression in the community: results from the Gutenberg Health Study. J Hypertens 2013;31:893-9.
21. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its prevalence and risk factor profile in the German general population. Dtsch Arztebl Int 2012;109:293-9.
22. Wild PS, Sinning CR, Roth A, Wilde S, Schnabel RB, Lubos E, et al. Distribution and categorization of left ventricular measurements in the general population: results from the population-based Gutenberg Heart Study. Circ Cardiovasc Imaging 2010;3:604-13.
23. Ichikawa K, Khamashta MA, Koike T, Matsuura E, Hughes GR. β2 glycoprotein-I reactivity of monoclonal anticardiolipin antibodies from patients with the antiphospholipid syndrome. Arthritis Rheum 1994;37:1453-61.
24. Ichikawa K, Tsutsumi A, Atsumi T, Matsuura E, Kobayashi S, Hughes GR, et al. A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β2-glycoprotein I-dependent anticardiolipin and anti-β2-glycoprotein I antibodies. Arthritis Rheum 1999;42:2461-70.
25. Favaloro EJ, Wong RC. Antiphospholipid antibody testing for the antiphospholipid syndrome: a comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology 2014;46:481-95.
26. Rutjes AW, Reitsma JB, Vandenbroucke JP, Glas AS, Bossuyt PM. Case-control and two-gate designs in diagnostic accuracy studies. Clin Chem 2005;51:1335-41.
27. Runchey SS, Folsom AR, Tsai MY, Cushman M, McGovern PD. Anticardiolipin antibodies as a risk factor for venous thrombo-embolism in a population-based prospective study. Br J Haema-tol 2002;119:1005-10.